ABSTRACT
Lung cancer is considered as the leading cause of cancer-related mortality worldwide. Non-small cell lung cancer (NSCLC) accounts for about 85% of primary lung cancer. Owing to the improved utilization of medical technological level and the popularization of health examinations, the detection rate of early-stage NSCLC is gradually increasing. The main treatment modalities for early-stage NSCLC are surgical resection and adjuvant chemotherapy. Platinum-based chemotherapy is recommended as the standard postoperative adjuvant treatment for patients with completely resected stageⅡ-ⅢA NSCLC. However, adjuvant therapy remains a controversial option in stageⅠB NSCLC. This review focuses on postoperative adjuvant therapy such as adjuvant chemotherapy, targeted therapy, and immunotherapy for completely resected stageⅠB NSCLC. Moreover, the biomarkers and prognostic factors of high-risk patients are discussed.
ABSTRACT
Objective To learn the situation of medical information privacy protection of a hospital and patient′s privacy demand for different medical information .Methods A 300-questionnaire survey was conducted at a tertiary hospital in Shanghai in April 2017 .The data were subject to descriptive analysis .Results The patients were generally satisfied with the hospital′s medical information privacy protection ,as 71％ of them (213/300)were satisfied ,and 13％ (39/300)of them experienced privacy exposure.Patients were most concerned with medical information from which others could identify them .Conclusions The State should promulgate rules and regulations for the protection of medical information privacy as soon as possible ;information technology need to be adopted to encrypt identifiable information ;a system of norms that can be followed need to be developed for the use of medical information ;hospitals should build a patient′s privacy protection system to comprehensively protect the privacy of patients .
ABSTRACT
Following an overview of the present big medical data sharing abroad, the paper identified the problems of the regional health information platform in data sharing and utilization as follows. Namely, poor data integration, low data availability, poor data security and privacy, unclear data sharing model, and poor data management accountability. On such basis, the authors made thoughtful studies in data quality management, information security and privacy protection and data sharing model. These efforts provide useful references for big health data integration sharing and open access.